Visiongain has published a new report Point of Care Diagnostic Market Forecast 2020- 2030: Forecasts by Product (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Hematology Testing, Drugs-of-abuse Testing, Fecal Occult Testing, and Other POC Products) By Mode (Prescription-based, and OTC), By End User (Clinics, Hospitals, Home Care Setting, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) Including Forecasts by Major Developed Countries and Developing Countries, Profiles of Leading Companies in the Market & PLUS COVID-19 Recovery Scenarios.
‘The global point of care diagnostics market was valued at $32,945 million in 2020 and is projected to reach $73,293 million in 2031’ says Visiongain’s lead analyst. Point-of-care diagnostics is as an investigation undertaken at the time of the consultation with instantaneous availability of results to make speedy and informed decisions in relation to patient care. It allows physicians and medical staff to accurately achieve real-time, lab-quality diagnostic results within minutes rather than hours. Recent years have seen significant advances in point-of-care diagnostics test and devices.
